Immunovia announces extraordinary general meeting

• Immunovia schedules an extraordinary general meeting in Lund on Oct. 29, 2026.
• Shareholders will vote on amending the articles to raise share-capital limits to SEK 24–96 million, SEK 30–120 million, or SEK 36–144 million.
• The meeting will also decide whether to ratify a rights issue of units, each comprising two shares and one warrant (TO 4).
• Warrants would be issued free of charge; each TO 4 would allow subscription for one new share at 110% of the share subscription price.
• Investors will also vote on authorizing the board to issue shares and TO 4 warrants to guarantors as underwriting compensation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovia AB published the original content used to generate this news brief on September 28, 2026, and is solely responsible for the information contained therein.